ANI Pharmaceuticals | ANIP - Assets


ANI Pharmaceuticals reported $1.49B in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
AbbVie USD 135.12B 1.35B Jun/2026
ANI Pharmaceuticals USD 1.49B 72.14M Jun/2026
Aurora Cannabis CAD 601.09M 174.2M Mar/2026
Canopy Growth CAD 1.12B 12.54M Mar/2026
Eli Lilly USD 142.28B 25.71B Jun/2026
Emergent BioSolutions USD 1.82B 69.9M Dec/2023
Heron Therapeutics USD 252.26M 6.05M Jun/2026
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Knight Therapeutics CAD 1.05B 2.28M Dec/2025
Nektar Therapeutics USD 763.27M 482.86M Mar/2026
Novartis USD 118.53B 7.58B Mar/2026
Omeros USD 200.57M 34.59M Jun/2025
Perrigo USD 7.61B 373.8M Jun/2026
Sun Pharmaceuticals INR 1.09T 50.79B Mar/2026
Teva Pharmaceutical Industries USD 39.86B 183M Jun/2026